Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 15, 2017

Total Value: $1.753B (100.0% shares, 0.0% debt)

Holdings (38)

UTHR UNITED THERAPEUTICS CORP DEL 15.3%
Value $268M Shares 1,868,815 Share Price $143.43 * Est. Cost/Share $88.34 Unrealized @ Report Date +44.5%
— ABIOMED INC 12.2%
Value $214M Shares 1,903,584 Share Price $112.68 Est. Cost/Share $30.32 Unrealized @ Report Date —
— CLOVIS ONCOLOGY INC 9.6%
Value $169M Shares 3,804,088 Share Price $44.42 Est. Cost/Share $53.87 Unrealized @ Report Date —
BMRN BIOMARIN PHARMACEUTICAL INC 9.3%
Value $162M Shares 1,960,219 Share Price $82.84 * Est. Cost/Share $77.21 Unrealized @ Report Date +11.4%
— AMAG PHARMACEUTICALS INC 6.6%
Value $116M Shares 3,344,620 Share Price $34.80 Est. Cost/Share $29.94 Unrealized @ Report Date —
— ALEXION PHARMACEUTICALS INC 5.0%
Value $87.33M Shares 713,742 Share Price $122.35 Est. Cost/Share $119.75 Unrealized @ Report Date —
— ZELTIQ AESTHETICS INC 4.3%
Value $74.89M Shares 1,720,763 Share Price $43.52 Est. Cost/Share $29.98 Unrealized @ Report Date —
INSM INSMED INC 4.1%
Value $72.06M Shares 5,446,516 Share Price $13.23 * Est. Cost/Share $14.56 Unrealized @ Report Date -6.3%
VNDA VANDA PHARMACEUTICALS INC 3.8%
Value $67.04M Shares 4,203,270 Share Price $15.95 Est. Cost/Share $8.70 Unrealized @ Report Date +84.7%
— WRIGHT MED GROUP N V 3.4%
Value $59.85M Shares 2,604,593 Share Price $22.98 Est. Cost/Share $23.37 Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 2.9%
Value $51.57M Shares 1,009,930 Share Price $51.06 Est. Cost/Share $40.00 Unrealized @ Report Date —
PRTA PROTHENA CORP PLC 2.8%
Value $48.89M Shares 993,855 Share Price $49.19 * Est. Cost/Share $30.77 Unrealized @ Report Date +79.3%
ACAD ACADIA PHARMACEUTICALS INC 2.5%
Value $44.18M Shares 1,532,030 Share Price $28.84 * Est. Cost/Share $29.57 Unrealized @ Report Date -10.5%
STAA STAAR SURGICAL CO 2.1%
Value $36.74M Shares 3,386,245 Share Price $10.85 * Est. Cost/Share $7.92 Unrealized @ Report Date +28.4%
— EPIZYME INC 2.1%
Value $36.73M Shares 3,035,796 Share Price $12.10 Est. Cost/Share $13.44 Unrealized @ Report Date —
— CELGENE CORP 1.9%
Value $34.17M Shares 295,240 Share Price $115.75 Est. Cost/Share $97.51 Unrealized @ Report Date —
— ARIAD PHARMACEUTICALS INC 1.9%
Value $33.36M Shares 2,682,017 Share Price $12.44 Est. Cost/Share $7.21 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 1.8%
Value $31.86M Shares 6,410,030 Share Price $4.97 * Est. Cost/Share $6.21 Unrealized @ Report Date +11.4%
— KARYOPHARM THERAPEUTICS INC 1.7%
Value $30.08M Shares 3,200,396 Share Price $9.40 Est. Cost/Share $20.34 Unrealized @ Report Date —
— MOMENTA PHARMACEUTICALS INC 1.5%
Value $26M Shares 1,727,380 Share Price $15.05 Est. Cost/Share $14.10 Unrealized @ Report Date —
GILD GILEAD SCIENCES INC 1.3%
Value $22.8M Shares 318,400 Share Price $71.61 * Est. Cost/Share $63.20 Unrealized @ Report Date -15.8%
— SHIRE PLC 1.2%
Value $21.14M Shares 124,100 Share Price $170.38 Est. Cost/Share $221.47 Unrealized @ Report Date —
— RIGEL PHARMACEUTICALS INC 0.6%
Value $9.94M Shares 4,176,623 Share Price $2.38 Est. Cost/Share $3.39 Unrealized @ Report Date —
— AIMMUNE THERAPEUTICS INC 0.4%
Value $7.765M Shares 379,727 Share Price $20.45 Est. Cost/Share $23.85 Unrealized @ Report Date —
EXAS EXACT SCIENCES CORP 0.3%
Value $5.304M Shares 396,976 Share Price $13.36 * Est. Cost/Share $12.83 Unrealized @ Report Date +25.8%
— SUNESIS PHARMACEUTICALS INC 0.2%
Value $4.208M Shares 1,162,473 Share Price $3.62 Est. Cost/Share $4.37 Unrealized @ Report Date —
ALGN ALIGN TECHNOLOGY INC 0.2%
Value $3.721M Shares 38,707 Share Price $96.13 * Est. Cost/Share $60.82 Unrealized @ Report Date +52.7%
— ALIMERA SCIENCES INC 0.2%
Value $3.255M Shares 3,013,793 Share Price $1.08 Est. Cost/Share $4.88 Unrealized @ Report Date —
— ACELRX PHARMACEUTICALS INC 0.2%
Value $2.685M Shares 1,032,715 Share Price $2.60 Est. Cost/Share $5.54 Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.1%
Value $1.503M Shares 123,686 Share Price $12.15 * Est. Cost/Share $6.71 Unrealized @ Report Date +58.1%
— INTREXON CORP 0.1%
Value $1.018M Shares 41,900 Share Price $24.30 Est. Cost/Share $28.82 Unrealized @ Report Date —
— CEMPRA INC 0.1%
Value $953K Shares 340,320 Share Price $2.80 Est. Cost/Share $22.71 Unrealized @ Report Date —
— IDERA PHARMACEUTICALS INC 0.1%
Value $925K Shares 616,355 Share Price $1.50 Est. Cost/Share $3.70 Unrealized @ Report Date —
— SOPHIRIS BIO INC 0.0%
Value $692K Shares 247,000 Share Price $2.80 Est. Cost/Share $2.60 Unrealized @ Report Date —
— ALCOBRA LTD 0.0%
Value $573K Shares 272,788 Share Price $2.10 Est. Cost/Share $5.98 Unrealized @ Report Date —
— HISTOGENICS CORP 0.0%
Value $506K Shares 302,922 Share Price $1.67 Est. Cost/Share $11.00 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 0.0%
Value $456K Shares 158,279 Share Price $2.88 Est. Cost/Share $9.72 Unrealized @ Report Date —
— ZOGENIX INC 0.0%
Value $358K Shares 29,500 Share Price $12.14 Est. Cost/Share $13.36 Unrealized @ Report Date —